cons of glp 1 drugs Your guide to GLP-1 side effects Updated Ranking and Side Effects
Description
Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024
IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits
The science behind 24% weight loss results explained.
A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year
Insulin and incretins are compounds with multiple effects on neurodegenerative processes
Learn the science
